Amedisys Inc (AMED)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,134,540 | 1,066,510 | 1,051,570 | 931,351 | 809,224 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,134,540K
= 0.00
Based on the provided data, Amedisys Inc's debt-to-equity ratio has consistently been reported as 0.00 for the years ending December 31, 2020 through December 31, 2024. This indicates that the company has been using primarily equity to finance its operations rather than relying on debt. A debt-to-equity ratio of 0.00 suggests that the company has no debt in its capital structure or a negligible amount compared to its equity.
Having a low or zero debt-to-equity ratio can be seen as a positive indicator of financial health as it signifies lower financial risk and less dependence on borrowed funds for operations or expansion. It also implies that the company may have better control over its financial obligations and less exposure to interest rate fluctuations.
However, it's important to note that while a low debt-to-equity ratio can be beneficial, it may also indicate missed opportunities for leveraging debt to potentially accelerate growth or take advantage of tax benefits associated with interest payments. Overall, Amedisys Inc's consistent 0.00 debt-to-equity ratio suggests a conservative financial approach with a focus on stability and equity financing.
Peer comparison
Dec 31, 2024